Trulieve Cannabis Corp. (TCNNF)
| Previous close | 11.80 |
| Open | 11.73 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 11.34 - 11.80 |
| 52-week range | 3.42 - 13.75 |
| Volume | |
| Avg. volume | 608,343 |
| Market cap | 2.12B |
| Beta (5Y monthly) | 1.51 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.28 |
| Earnings date | 09 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 14.50 |
- Market Exclusive
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Key Takeaways; Cannabis Sector Canopy Growth received ISS recommendation for creation of exchangeable shares. Trulieve to hold first quarter 2024 results conference call at the beginning of May. Goodness Growth announced sale of Vireo Health of New York in effort to address financial constraints. Avant Brands entered German market through IM Cannabis deal. Key Takeaways; […]
PR NewswireTrulieve Cannabis Corp. to Hold First Quarter 2024 Results Conference Call on May 9, 2024
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., will hold a conference call on Thursday, May 9, 2024 at 8:30 AM Eastern Time following the release of its first quarter 2024 financial results.
- PR Newswire
Trulieve Announces April 2024 Event Participation
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced planned event participation in April.
